BioLASCO Taiwan Co., Ltd. (TPEX:6662)
Taiwan · Delayed Price · Currency is TWD 28.60
+0.05 (0.18%)
May 29, 2026, 1:30 PM CST
BioLASCO Taiwan Market Cap
BioLASCO Taiwan has a market cap or net worth of 732.5 million as of May 29, 2026. Its market cap has decreased by -15.63% in one year.
Market Cap
732.50M
Enterprise Value
694.41M
Revenue
263.81M
Ranking
n/a
PE Ratio
16.88
Stock Price
28.60
Market Cap Chart
Since January 4, 2018, BioLASCO Taiwan's market cap has decreased from 1.58B to 732.50M, a decrease of -53.67%. That is a compound annual growth rate of -8.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 732.50M | -7.74% |
| Dec 31, 2025 | 793.97M | -6.34% |
| Dec 31, 2024 | 847.76M | -0.30% |
| Dec 29, 2023 | 850.32M | 11.22% |
| Dec 30, 2022 | 764.52M | -1.97% |
| Dec 30, 2021 | 779.89M | -13.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 4, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LabTurbo Biotech | 1.00B |
| Lukas Biomedical | 994.52M |
| TCI GENE | 976.32M |
| Taiwan Advance Bio-Pharmaceutical | 896.40M |
| NatureWise Biotech & Medicals | 895.40M |
| Neith | 833.08M |
| MegaPro Biomedical | 821.96M |
| SynCore Biotechnology Co.,Ltd | 685.71M |